Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Irena Pekker"'
Autor:
Patrick Danaher, Sarah Warren, Rongze Lu, Josue Samayoa, Amy Sullivan, Irena Pekker, Brett Wallden, Francesco M. Marincola, Alessandra Cesano
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-17 (2018)
Abstract The Tumor Inflammation Signature (TIS) is an investigational use only (IUO) 18-gene signature that measures a pre-existing but suppressed adaptive immune response within tumors. The TIS has been shown to enrich for patients who respond to th
Externí odkaz:
https://doaj.org/article/b2cb84032e6c41d894a0979aff381d60
Autor:
Zachary B Lippman, Oded Cohen, John P Alvarez, Mohamad Abu-Abied, Irena Pekker, Ilan Paran, Yuval Eshed, Dani Zamir
Publikováno v:
PLoS Biology, Vol 6, Iss 11, p e288 (2008)
Variation in the branching of plant inflorescences determines flower number and, consequently, reproductive success and crop yield. Nightshade (Solanaceae) species are models for a widespread, yet poorly understood, program of eudicot growth, where s
Externí odkaz:
https://doaj.org/article/a70f3af2797b460ca1fcd55fe5ddd4c7
Autor:
Rongze Lu, Sarah Warren, Josue Samayoa, Patrick Danaher, Amy Sullivan, Brett Wallden, Irena Pekker, Francesco M. Marincola, Alessandra Cesano
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-17 (2018)
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-17 (2018)
The Tumor Inflammation Signature (TIS) is an investigational use only (IUO) 18-gene signature that measures a pre-existing but suppressed adaptive immune response within tumors. The TIS has been shown to enrich for patients who respond to the anti-PD
Autor:
Irena Pekker, David Zhang, Emily R Evans, Celine Ngouenet, Alessandro Pinto, Joseph M. Beechem, Lucia R. Wu, Juexiao Wang, John Z. Fang, Richard Kemble Boykin, Philippa J. Webster
Publikováno v:
Nature methods
In silico designed nucleic acid probes and primers often fail to achieve favorable specificity and sensitivity tradeoffs on the first try, and iterative empirical sequence-based optimization is needed, particularly in multiplexed assays. Here, we pre
Autor:
Ayami Nakagawa, Hirokazu Tanaka, Hiroshi Fukazawa, Irena Pekker, Toshiro Ito, Shoko Kojima, Takaaki Ishikawa, Yoko Matsumura, Mayumi Iwasaki, Simon Vial-Pradel, Yasunori Machida, Yuval Eshed, Hidekazu Iwakawa, Yuichiro Watanabe, Hiro Takahashi, Yoshihisa Ueno, Chiyoko Machida
Publikováno v:
Development. 140:1958-1969
Leaf primordia are generated at the periphery of the shoot apex, developing into flat symmetric organs with adaxial-abaxial polarity, in which the indeterminate state is repressed. Despite the crucial role of the ASYMMETRIC LEAVES1 (AS1)-AS2 nuclear-
Autor:
Sean Ferree, Brett Wallden, S. Zimmerman, Naeem Dowidar, Carl Schaper, E. Harris, Sarah E. Church, Celine Ngouenet, Patrick Danaher, Simina Popa, Irena Pekker, Amy Sullivan, A. Bergdahl
Publikováno v:
Annals of Oncology. 29:viii425
Autor:
Patrick Danaher, Brett Wallden, Simina Popa, Xing Ren, Carl Schaper, Sean Ferree, Sarah E. Church, Irena Pekker, Naeem Dowidar, Celine Ngouenet, Amy Sullivan
Publikováno v:
Journal of Clinical Oncology. 36:203-203
203 Background: The development and analytical performance of the Tumor Inflammation Signature (TIS) assay has been described previously. The TIS is an investigational use RNA expression assay on the nCounter Dx Analysis System, which is being evalua
Publikováno v:
Journal of Experimental Botany
Wild peppers (Capsicum spp.) are either annual or perennial in their native habitat and their shoot architecture is dictated by their sympodial growth habit. To study shoot architecture in pepper, sympodial development is described in wild type and i
Publikováno v:
Plant Molecular Biology. 49:429-438
Excess of free iron is thought to harm plant cells by enhancing the intracellular production of reactive oxygen intermediates (ROI). Cytosolic ascorbate peroxidase (cAPX) is an iron-containing, ROI-detoxifying enzyme induced in response to iron overl
Autor:
Mingdong Liu, Afshin Mashadi-Hossein, Irena Pekker, Simina Popa, James Storhoff, Naeem Dowidar, Brett Wallden, Sean Ferree, Patrick Danaher, Matthew J. Marton, Celine Ngouenet, Amy Sullivan
Publikováno v:
Journal of Clinical Oncology. 35:8-8
8 Background: Pembrolizumab is a humanized anti-PD1 antibody that is approved for use in advanced melanoma, recurrent or metastatic head and neck squamous cell carcinoma, and metastatic non-small-cell lung cancer. It has also shown clinical activity